Post by BDO USA

March marked a slight IPO drought for the biotech industry, but our Life Science National Leader Brad Stewart isn't ready to write them off yet. He spoke to Fierce Biotech's James Waldron about the options life sciences has to secure the fresh capital they need for the rest of the year. Full article: https://bdousa.com/4cdTSj1